The term "zero prostate" typically refers to achieving an undetectable or zero prostate-specific antigen (PSA) blood test level following definitive curative treatment for prostate cancer, such as a radical prostatectomy or successful radiation therapy. In oncology, reaching a postoperative PSA level below 0.1 ng/mL signifies that biochemical remission has been achieved and that no detectable residual cancerous tissue or biochemical recurrence is active within the body at that time, serving as a primary indicator of successful therapeutic intervention.